Garsorasib

DB21581InvestigationalSmall molecule

Garsorasib is a small molecule drug. The usage of the INN stem '-rasib' in the name indicates that Garsorasib is a Ras protein inhibitor. Garsorasib has a monoisotopic molecular weight...

Mechanism: Pharmacologically active on GTPase KRas
Curator reviewed
Formula / weight: C₃₂H₃₂F₂N₈O₂ · 598.659 g/mol (avg)

Resolves to

Compound

UNIIP491NE9G6ZCAS2559761-14-5ChEMBLCHEMBL5095066

Structure

InChIKeyDKFRWZJCNPETGI-SJORKVTESA-NSMILESC[C@@H]1CN([C@@H](C)CN1C(=O)C=C)C1=NC(=O)N(C2=NC(=C(F)C=C12)C1=C(N)C=CC=C1F)C1=C(N=CN=C1C1CC1)C1CC1

Targets

P01116KRAS

What you can answer from here — as of September 13, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Garsorasib, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account